India has approved Qfitlia (Fitusiran), a new treatment designed to prevent or reduce bleeding episodes in people living with ...
Panel to feature Aditee Kambli, Bharat Serums & Vaccines; Dr. Sushant Kumar, ImmunoACT; Satish Makkina, Procell Biologics; Dr ...
The newly approved regimen offers a chemotherapy-free perioperative approach and is authorised for use across all 27 EU ...
With the approval, Cosentyx becomes the first and only interleukin-17A (IL-17A) inhibitor approved in Europe for adults with ...
Speakers include Parizad A. Elchidana, ACG World; Dr. Kiran Marthak, Veeda Life Sciences; Dr. Ravikrishna Chebolu, CSIR ...
Allergan Aesthetics is presenting new clinical findings at AMWC Dubai.
Based on I CAN Phase III trial results from prespecified interim analysis in which Ultomiris demonstrated 43.4% reduction in ...
The initiative will initially focus on patients with desmoid tumors and neurofibromatosis type 1 with plexiform neurofibromas ...
Launched in collaboration with Ameelio Healthcare Private Limited, the laboratory is aimed at expanding access to affordable, ...
Prolific has reported a productivity milestone of 21 grams per litre in a 15-day intensified fed-batch run for a monoclonal ...
Biotech firm Zealand Pharma has reported positive Phase 1 multiple ascending dose (MAD) results for ZP9830, its ...
Eli Lilly and Company has reported positive one-year results from a Phase 3 trial of Omvoh (mirikizumab-mrkz) in children and adolescents aged 6 to 17 with moderately to severely active ulcerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results